COMMUNIQUÉS West-GlobeNewswire

-
Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033
18/10/2018 -
Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA
18/10/2018 -
Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients’ Perspective
18/10/2018 -
Delcath Announces Enrollment of First Patient in ALIGN Trial
18/10/2018 -
Parkview Health First to Activate New SMART® and FHIR® Technology Standards Through Healthwise
18/10/2018 -
Opiant Pharmaceuticals Announces Receipt of National Institutes of Health Grant by Walter Reed Army Institute of Research and SUNY Upstate Medical University for Development of a Heroin Vaccine
18/10/2018 -
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
18/10/2018 -
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
18/10/2018 -
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
18/10/2018 -
Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference
18/10/2018 -
MSI Methylation Sciences, Inc. (MSI) provides an update on its corporate activities, including its recent arbitration award of $20 million USD against Quark Venture Inc (Quark)
18/10/2018 -
Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis
18/10/2018 -
Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe
18/10/2018 -
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ to be Presented at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting
18/10/2018 -
T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date
18/10/2018 -
Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018
18/10/2018 -
Notice of Results
18/10/2018 -
Homology Medicines Presents Long-Term Efficacy Data of a Single Dose of Gene Therapy Development Candidate for Treatment of Phenylketonuria
18/10/2018 -
Axsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Alzheimer’s Disease Agitation
18/10/2018
Pages